Wenwen Xue1,2,3,4, Ming-Ming Zhu1,2,3,4, Bi-Jun Zhu1,2,3, Jian-Nan Huang1,2,3,4, Qian Sun1,2,3, Yu-Yu Miao1,2,3, Hai-Dong Zou5,6,7,8. 1. Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2. Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China. 3. Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China. 4. Department of Preventative Ophthalmology, Shanghai Eye Diseases Prevention and Treatment Center, No. 380, Kangding Road, Jingan District, Shanghai, 200040, China. 5. Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. zouhaidong@263.net. 6. Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China. zouhaidong@263.net. 7. Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China. zouhaidong@263.net. 8. Department of Preventative Ophthalmology, Shanghai Eye Diseases Prevention and Treatment Center, No. 380, Kangding Road, Jingan District, Shanghai, 200040, China. zouhaidong@263.net.
Abstract
PURPOSE: To observe the long-term changes in dry eye symptoms and vision-related quality of life in age-related cataract patients after phacoemulsification. METHODS: A total of 101 cataract patients after phacoemulsification combined with IOL implantation (Ph-IOL) in one eye were enrolled. Visual acuity, tear film breakup time (BUT), and Schirmer test 1 (ST1) were measured before and 1, 3, and 6 months after surgery. Ocular Surface Disease Index (OSDI) scores were used to evaluate the severity of dry eye symptoms. Utility values were assessed by the time trade-off (TTO), standard gamble for death (SGD), standard gamble for blindness (SGB) and rating scale (RS). RESULTS: The average LogMAR visual acuity in the operated eye was 1.35 ± 0.50 and increased rapidly after Ph-IOL, approaching a peak at 3 months (0.26 ± 0.15). The BUT and ST1 results decreased abruptly 1 month after surgery and gradually recovered until 6 months. OSDI scores increased significantly after surgery and gradually decreased until 6 months. Utility values evaluated by TTO, SGD, SGB and RS before surgery were 0.67 ± 0.19, 0.75 ± 0.15, 0.67 ± 0.20 and 0.2 ± 0.18, respectively, and increased to 0.91 ± 0.06, 0.98 ± 0.04, 0.92 ± 0.52 and 0.91 ± 0.06, 6 months after. Utility values measured with TTO, SGB or RS correlated significantly (P < 0.05) with visual acuity and OSDI scores pre- and postoperatively. CONCLUSIONS: Dry eye symptoms persist more than 3 months after Ph-IOL. Utility values were negatively influenced by dry eye symptoms.
PURPOSE: To observe the long-term changes in dry eye symptoms and vision-related quality of life in age-related cataractpatients after phacoemulsification. METHODS: A total of 101 cataractpatients after phacoemulsification combined with IOL implantation (Ph-IOL) in one eye were enrolled. Visual acuity, tear film breakup time (BUT), and Schirmer test 1 (ST1) were measured before and 1, 3, and 6 months after surgery. Ocular Surface Disease Index (OSDI) scores were used to evaluate the severity of dry eye symptoms. Utility values were assessed by the time trade-off (TTO), standard gamble for death (SGD), standard gamble for blindness (SGB) and rating scale (RS). RESULTS: The average LogMAR visual acuity in the operated eye was 1.35 ± 0.50 and increased rapidly after Ph-IOL, approaching a peak at 3 months (0.26 ± 0.15). The BUT and ST1 results decreased abruptly 1 month after surgery and gradually recovered until 6 months. OSDI scores increased significantly after surgery and gradually decreased until 6 months. Utility values evaluated by TTO, SGD, SGB and RS before surgery were 0.67 ± 0.19, 0.75 ± 0.15, 0.67 ± 0.20 and 0.2 ± 0.18, respectively, and increased to 0.91 ± 0.06, 0.98 ± 0.04, 0.92 ± 0.52 and 0.91 ± 0.06, 6 months after. Utility values measured with TTO, SGB or RS correlated significantly (P < 0.05) with visual acuity and OSDI scores pre- and postoperatively. CONCLUSIONS:Dry eye symptoms persist more than 3 months after Ph-IOL. Utility values were negatively influenced by dry eye symptoms.
Authors: Abdelrahman M Elhusseiny; Ali A Khalil; Reem H El Sheikh; Mohammad A Bakr; Mohamed Gaber Eissa; Yasmine M El Sayed Journal: Int J Ophthalmol Date: 2019-10-18 Impact factor: 1.779
Authors: Carlo Cagini; Giovanni Torroni; Marco Mariniello; Giampiero Di Lascio; Gianluca Martone; Angelo Balestrazzi Journal: Int Ophthalmol Date: 2021-05-06 Impact factor: 2.031